UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X] Quarterly report pursuant to Section 13 or 15(d) of the Securities  Exchange
Act of 1934 For the quarterly period ended: March 31, 2000

[ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 For the transition period from _______ to _________

                                          Commission file number: 000-25557

                             AGRI BIO-SCIENCES, INC.
        (Exact name of small business issuer as specified in its charter)

                  Delaware                                 76-0481583
       (State or other jurisdiction of                  (I.R.S. Employer
       incorporation or organization                    Identification No.)

       5211 Court of York, Houston, Texas                       77069
      (Address of principal executive officer)                (Zip Code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No ___

APPLICABLE  ONLY TO  ISSUERS  INVOLVED  IN  BANKRUPTCY  PROCEEDINGS  DURING  THE
PRECEDING FIVE YEARS

Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court Yes ___ No ___

APPLICABLE ONLY TO CORPORATE ISSUERS

The number of shares of common stock, $0.001 par value, outstanding as March 31,
2000: 11,141,619 shares

Transitional Small Business Disclosure Format (check one):   Yes ___   No  X
                                                                          --


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                           PERIOD ENDED MARCH 31, 2000

                                      INDEX
<TABLE>
<CAPTION>

PART I.  FINANCIAL INFORMATION                                                                                 Page

         Item 1.  Financial Statements

         Condensed financial statements of Agri Bio-Sciences, Inc.:

<S>                                                                                                             <C>
                  Balance Sheet as of March 31, 2000                                                              3

                  Expense  Statements  for the three months ended March 31, 2000
                  and March 31, 1999 and period from May 30, 1995 (Date
                  of Inception) to March 31, 2000                                                                 4

                  Statements  of Cash Flows for the three months ended March 31,
                  2000 and March 31, 1999 and period from May 30,
                  1995 (Date of Inception) to March 31, 2000                                                      5

                  Notes to financial statements                                                                   6


         Item 2.  Plan of Operations                                                                              7

PART II. OTHER INFORMATION

         Item 6.  Exhibits and Reports on Form 8-K                                                               10

                  (a)      Exhibits

SIGNATURE                                                                                                        11
</TABLE>


<PAGE>


PART I.   FINANCIAL INFORMATION

Item 1.   Financial Statements

                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                                  Balance Sheet
                                 March 31, 2000
<TABLE>

ASSETS

<S>                                                                                                       <C>
  Cash                                                                                                    $  3,986

  Fertilizer plant and equipment, net                                                                      161,886
                                                                                                          --------

         TOTAL ASSETS                                                                                     $165,872
                                                                                                          ========


LIABILITIES

     Accounts payable                                                                                     $ 15,391
  Accrued expenses                                                                                          14,892
  Due to current stockholders                                                                              148,000
  Due to former stockholder                                                                                100,000
                                                                                                          --------

         TOTAL LIABILITIES                                                                                 278,283
                                                                                                          --------


STOCKHOLDERS' EQUITY
  Preferred stock, $.001 par value,
         5,000,000 shares authorized,
         0 shares issued and outstanding
  Common stock, $.001 par value,
         20,000,000 shares authorized,
         11,000,000 issued and outstanding                                                                  11,000
  Paid in capital                                                                                          612,150
  Deficit Accumulated During the
      Development Stage                                                                                   (735,561)
                                                                                                          --------

         TOTAL STOCKHOLDERS' EQUITY (DEFICIT)                                                             (112,411)
                                                                                                          --------

         TOTAL LIABILITIES AND
               STOCKHOLDERS' EQUITY                                                                       $165,872
                                                                                                          ========

</TABLE>









                       See notes to financial statements.


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                             Statements of Expenses
                   Three Months Ended March 31, 2000 and 1999,
              and the Period from May 30, 1995 (Date of Inception)
                                to March 31, 2000

<TABLE>
<CAPTION>
                                                                                                       May 30, 1995
                                                                                                     (Inception) to
                                                                                                        March 31,
                                                                    2000                1999              2000
                                                               -----------       -------------        --------
EXPENSES
<S>                                                              <C>                <C>                  <C>
  Fees paid for services
      by stockholders                                                                                    $ 188,400
  Other administrative expenses                                  $  12,938          $  32,612              375,426
  Inventory writedown                                                                                      100,000
  Interest                                                           3,962                                  59,735
  Depreciation                                                       1,250              1,250               12,000
                                                                 ---------          ---------            ---------

         NET (DEFICIT)                                           $( 18,150)         $( 33,862)           $(735,561)
                                                                 =========          =========            =========

(Loss) per common share                                          $(    .00)         $(    .00)
Weighted average
   shares outstanding                                           11,000,000         10,900,000



</TABLE>























                       See notes to financial statements.


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                             Statements of Cash Flow
                 Three Months Ended March 31, 2000 and 1999, and
                the Period from May 30, 1995 (Date of Inception)
                                to March 31, 2000
<TABLE>
<CAPTION>

                                                                                                       May 30, 1995
                                                                                                     (Inception) to
                                                                                                        March 31,
                                                                        2000             1999             2000
                                                                  ------------      -----------      ----------
CASH FLOW FROM OPERATING ACTIVITIES
<S>                                                                  <C>               <C>               <C>
  Net loss                                                           $( 18,150)        $( 33,862)        $(735,561)
  Adjustments to reconcile net
     income to net cash provided by
     operating activities:
   Depreciation                                                          1,250             1,250            12,000
   Writedown of inventory                                                                                  100,000
   Common stock issued for services                                                       87,650
   Contribution of imputed interest                                      2,500                              42,500
     Increase in accounts payable                                           92            21,059            15,392
   Increase in accrued expenses                                          1,615                              12,391
                                                                    ------------     -----------       ------------
                  NET CASH USED BY
                  OPERATING ACTIVITIES                                ( 12,693)         ( 11,553)         (465,628)
                                                                     ---------         ---------         ---------

CASH FLOWS FROM INVESTING ACTIVITIES
  Plant site construction and
         equipment purchases                                                                              ( 73,886)

CASH FLOWS FROM FINANCING ACTIVITIES
  Sales of common stock for cash                                                                           895,500
  Advances by a founding shareholder                                                                        72,000
  Cash paid to repurchase shares
         from a founding shareholder                                                                      (500,000)
  Advances by other shareholders                                                                            76,000
                                                                                                          ---------
                  NET CASH PROVIDED BY
                  FINANCING ACTIVITIES                                                                     543,500
                                                                                                         ---------

NET INCREASE (DECREASE) IN CASH                                     $( 12,693)         $( 11,553)        $   3,986
CASH AT BEGINNING OF PERIOD                                            16,679             11,989
                                                                     ---------           ---------      ----------
CASH AT END OF PERIOD                                               $   3,986          $     436         $   3,986
                                                                      =========          =========         =========


SUPPLEMENTAL DISCLOSURES
  Interest paid                                                     $       0          $       0         $       0
  Non-cash investing and
         financing activities
   Contribution of plant site at inception                                                                 100,000
   Purchase of bagged fertilizer for note payable                                                          100,000
</TABLE>

                       See notes to financial statements.
<PAGE>

                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                             Statements of Cash Flow
                   Three Months Ended March 31, 2000 and 1999,
              and the Period from May 30, 1995 (Date of Inception)
                                to March 31, 2000
<TABLE>
<CAPTION>


                                                                                                       May 30, 1995
                                                                                                     (Inception) to
                                                                                                        March 31,
                                                                     2000             1999               2000
                                                               ------------      -----------         -----------

<S>                                                                  <C>             <C>                <C>
NET INCREASE (DECREASE) IN CASH
   (from previous page)                                          $( 12,693)      $ (11,553)          $   3,986
CASH AT BEGINNING OF PERIOD                                         16,679          11,989
                                                                   ---------     ---------          ------------

CASH AT END OF PERIOD                                            $   3,986       $     436           $   3,986
                                                                  =========       =========         =========


SUPPLEMENTAL DISCLOSURES
  Interest paid                                                  $       0       $   2,710          $       0
  Non-cash investing and
         financing activities
   Contribution of plant site at inception                                                             100,000
   Purchase of bagged fertilizer for note payable                                                      100,000




</TABLE>





















                       See notes to financial statements.


<PAGE>


                                PLAN OF OPERATION

         Agri Bio-Sciences,  Inc., a Delaware corporation (the "Company"),  is a
developmental  stage company formed for the production of a fertilizer  known as
"Micro Min." It has not yet commenced full-scale  production  activities and has
not generated any revenues from operations. While there can be no assurance that
the Company will be able to generate  meaningful  revenues or achieve profitable
operations,  the Company has received its first purchase order for Micro Min and
expects to receive  additional  purchase orders in the near future.  The Company
had begun very  preliminary  efforts to procure an initial  market maker for the
Company's  Common Stock,  par value $.001 per share  ("Common  Stock"),  so that
public trading in the Common Stock could commence in the United States.  Because
of the  Company's  close  connection  to the country of Mexico,  the Company has
suspended these efforts for the present.  However, the Company is now seeking to
establish  a trading  market  for the  Common  Stock in Mexico and has engage an
attorney located in Mexico for this purpose.

EXCLUSIVE SALE AND PURCHASE ARRANGEMENT:

         The Company was formed  solely for the purpose of  manufacturing  Micro
Min and does not  intend  to  engage  in the sale and  marketing  of Micro  Min.
Instead, Global Farm Sciences, Inc., a Texas corporation ("Global"),  was formed
in  December  1997 by Lester  Stephens,  M. Manny  Kalish and  Patrick N. Morgan
(founders and board members of the Company) for the purpose of selling Micro Min
to  foreign  entities.  On August  27,  1998,  the  Company  signed a  five-year
exclusive product sales agreement with Global. This Agreement requires Global to
purchase  2,000  metric  tons of Micro  Min  during  the year  1999 and 2000 and
thereafter  purchase 3,000 metric tons of Micro Min during each succeeding year.
Global  must pay  $620.00  per  metric  ton in United  States  dollars,  FOB the
Company's plant facility in Bay Springs,  Mississippi.  Global must remit 50% of
the  purchase  price with each  purchase  order for Micro Min  forwarded  to the
Company.  (This  initial  amount  provides  the Company with  adequate  funds to
produce  one metric ton of product  and thereby  provides  the Company  with the
necessary funds to keep the plant in operation).  Thereafter,  Global must remit
the remaining 50% payment of its purchase  order to the Company within ninety 90
days of its receipt of the product FOB the plant.  The Global  agreement  may be
terminated prior to its five-year term upon the occurrence of certain  customary
termination  events,  such as breach of contract or  bankruptcy.  Global did not
purchase  the required  2,000  metric tons of Micro Min in 1999.  The Company is
currently  forebearing  from any action against Global on the belief that Global
will be able to remedy in the  future  its  failure  to  purchase  the  required
amount.

         During the quarter  ended  September  30, 1999,  the Company and Global
realized that the success of Global's business  activities in Mexico was limited
due to Global's  status as a foreign  corporation in that country.  Accordingly,
with the knowledge and consent of the Company, Global has been employing Ciences
Agro  Ambientales,  S.A.  de C.V.  ("CIAGAM")  to  undertake  the  sales-related
activities that Global was originally to undertake.  CIAGAM is indirectly  owned
by certain  members of the  Company's  Board of  Directors,  and is a registered
Mexican  corporation  fully authorized under Mexican corporate law. Global's use
of CIAGAM for sales-related  activities is expected for the foreseeable  future.
While there had been  discussions  of a formal  assignment to CIAGAM of Global's
rights and  obligations  under its exclusive  product sales  agreement  with the
Company, such an assignment is not presently expected.

STATUS OF SALES EFFORTS:

         For  some  time,  Global  had been  holding  discussions  with  various
governmental,  quasi--governmental  and industry parties, who would serve as the
primary  distributor  of  Micro  Min in  Mexico.  These  parties  have  included
Fertilizantes  Nacionales,  S.A. de C.V., the Mexican federal and state Colleges
of Agricultural  Engineers,  and INTAGRO, a company based in Veracruz,  Mexican.
These discussions failed to produce a definitive agreement. Because of the delay
in  establishing  a formal  relationship  with any  large  sales  force,  CIAGAM
(assuming the role previously  undertaken by Global) has been making sales calls
on  critical  governmental  and  quasi-governmental  agencies as well as private
businesses.  CIAGAM has reached an  agreement in principle  with  AGROFERMEX,  a
Mexican  fertilizer  distributor  having  250  offices,  regarding  AGROFERMEX's
serving as a non-exclusive distributor of Micro Min in Mexico. This agreement in
principle  has not yet produced a definitive,  legally  binding  agreement,  and
whether or not a definitive,  legally binding agreement will be executed can not
now be determined.

         In addition to CIAGAM's agreement in principle with AGROFERMEX,  CIAGAM
received  an  initial  purchase  order  for 290  metric  tons of Micro  Min from
Asesoria Integral Agrupecuaria,  S.A. de C.V. ("ASIA"), a fertilizer distributor
in Mexico. One hundred twenty (120) metric tons of Micro Min are already located
in warehouses in Mexico. Another 130 metric tons of Micro Min are located at the
Company's  plant  facility in Bay Springs,  Mississippi,  bagged and ready to be
shipped.  The Company is currently delaying delivery of this order,  pending the
installation  of  the  first  laboratory  in  Mexico  discussed  in  "LABORATORY
OPERATION"  below.  Such  installation and the delivery of part of this order is
expected  within the next 60 days. As a result of the ASIA purchase  order,  the
Company expects to realize revenues in the near future. Management believes that
CIAGAM (or  another  primary  distributor  in Mexico)  will  receive  additional
purchase  orders from ASIA in the future,  although there can be no assurance in
this regard.

         Moreover, the Company is also working with approximately 800 farmers in
the  state  of  Guanajuato,  Mexico  who  have  indicated  a  desire  to  form a
co-operative  and have the Company install a laboratory on their behalf.  On the
average,  each of these farmers has approximately  700 hectares,  for a total of
approximately  560,000  hectares or  approximately  1,400,000 acres. At a bag of
Micro  Min per  acre,  approximately  14,000  metric  tons of Micro Min would be
required  to serve the  co-operative.  At a profit of $305 per metric  ton,  the
Company  would  realize an aggregate  profit of  approximately  $4,270,000.  The
Company  expects that an  affiliated  entity will  establish,  own and operate a
laboratory  for the  benefit  of the  co-operative.  This  project  is in a very
preliminary  stage, and there can be no assurance that this project will ever be
completed in the scope currently being contemplated, if at all.

BANK FINANCING SALES:

         CIAGAM  has  recently  established  a  relationship  with the  Banco de
Mexico,  the national bank of Mexico. The Banco de Mexico has indicated a desire
to establish a credit line  sufficient for Mexican  farmers to purchase  certain
items of agriculture  necessary for growing crops. Although CIAGAM and the Banco
de Mexico have not agreed upon  definitive  terms nor  entered  into  definitive
agreements  regarding  the line of credit,  current  discussions  are  revolving
around  certain  terms.  First,  the line of credit is  expected to have a total
amount ranging from $425,000 to $1.2 million. This amount of funding is expected
to service  adequately  an  eight-state  targeted  area in Mexico.  In addition,
amounts  advanced  on the line of  credit  to  farmers  will be due and  payable
approximately 90 days after the advance.  Moreover, as is customary, the line of
credit  would  require the  farmers to place  their land in trust as  collateral
against  the  amounts  advanced.  Finally,  CIAGAM is expected to be required to
guarantee a  comparatively  small portion of each advance on the line of credit.
Despite the current  status of the  negotiations  regarding  the line of credit,
there  can  be  no  assurance  that  CIAGAM  will  successfully   conclude  such
negotiations  and  establish  a line of  credit  with the Banco de Mexico or any
other lender.

LABORATORY OPERATION:

         At one point, the Company intended to forego the actual  establishment,
ownership  and  operations  of  laboratories  and instead  license the Company's
software to Intertek  Testing  Services,  a prominent  international  laboratory
testing company ("ITS"), for use in ITS's existing and future laboratories.  The
Company and ITS never  reached a definitive  agreement  in this regard.  Now the
Company plans to license its software to CIAGAM,  which will be responsible  for
the actual establishment,  ownership and operations of the laboratories.  CIAGAM
expects  to  install  its  first  laboratory  within  the next 60  days.  It has
available  funds in the amount of $150,000 for this purpose and expects to raise
an additional  $250,000.  While  management of CIAGAM is confident  that it will
raise the $250,000  additional amount in the immediate  future,  there can be no
assurance  in this  regard.  CIAGAM  originally  expected  to  locate  the first
laboratory in a double-wide,  pre-fabricated building on the outskirts of Mexico
City to service  farmers in the state of Morelos.  However,  two farmers' unions
located in the state of Sinaloa  have  approached  CIAGAM  with a view of having
CIAGAM  locate the first  laboratory  in Sinaloa to service  farmers in Sinaloa.
These  farmers'  unions have offered to provide a building for housing the first
laboratory.  CIAGAM  expects to make a  decision  on the  location  of its first
laboratory in the immediate future.  Regardless of where the first laboratory is
located and whom it  services,  this  laboratory  will  receive soil samples and
process  them using the  Company's  computer  copyrighted  software  to complete
analytical  reports that depict the present  condition of the farmers' soil. The
reports will also  recommend the exact  fertilizers  to be used both in kind and
amounts on a per acre basis.  Management  believes  that a service like this has
never  before  available  to the  farmers of Mexico.  Once the first  laboratory
achieves acceptable  performance levels,  CIAGAM expects to establish additional
laboratories, eventually to service all of Mexico.

CORPORATE FUTURE GOALS:

         The Company  (through  CIAGAM)  intends to continue to pursue  sales of
Micro Min in Mexico and possibly  complete broad product sales  agreements  with
AGROFERMEX or some other firm or  organization  having a large sales force.  The
Company had  contemplated  establishing  a sales  program in Columbia.  However,
certain  instabilities  in that  country have caused the Company to postpone any
such  effort.  Although  the Company  will be involved in the  establishment  of
CIAGAM's first  laboratory  only to the extent of the licensing of the Company's
software,  the Company  expects that the  installation  of this  laboratory will
greatly further the Company's business.

CAPITAL REQUIREMENTS, RESEARCH AND DEVELOPMENT AND EQUIPMENT EXPENDITURES:

         The Company does not believe that it will need any  financing  over the
next 12 months. Management believes that the Company will be able to finance its
operations  through  its  receipt of down  payments  in the amount of 50% of the
purchase price of each purchase  order issued by Global.  Such down payments are
expected to cover all direct costs of producing the related product. The Company
has only minimal  overhead,  which has thus far been  financed  through  amounts
advanced by certain  directors of the Company.  These  directors  have indicated
that they intend to continue to provide limited financing of overhead,  but they
are under no legal obligation to do so and may cease at any time.

         Moreover,  the Company does not intend to conduct any further  research
and  development  over the next 12 months.  However,  if CIAGAM  meets its sales
expectations,  the  Company  expects  to add  (during  the  next  12  months)  a
California  Pellet Mill pelletizer and sufficient  additional  employees to meet
the demand for additional production.

PART II. OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

                  (a)      The following exhibits are filed with this Quarterly
                           Report or are incorporated herein by reference:

                  Exhibit

                  Number                    Description

                   27                       Financial Data Schedule

                  (b)      Reports on Form 8-K

                           None


<PAGE>


                                    SIGNATURE

         In accordance with the requirements of the Exchange Act, the Registrant
has duly  caused  this  Report to be signed  on its  behalf by the  undersigned,
thereunto duly authorized.

                                   AGRI BIO-SCIENCES, INC.
                                  (Registrant)

                                   By: /s/Lester H. Stephens

                                   Lester H. Stephens,
                                   President
                                  (Principal Executive
                                   Officer, Principal
                                   Financial Officer and
                                   Principal Accounting
                                   Officer)


Dated: May 18, 2000